Cargando…

PB2361: PREDIGA, EDUCATIONAL AND DIAGNOSIS PROJECT IN ACID SPHINGOMYELINASE DEFICIENCY DISEASE (ASMD) AND GAUCHER DISEASE (GD): RESULTS TO THE OBJECTIVE ACHIEVED OF 200 PATIENTS ANALYZED.

Detalles Bibliográficos
Autores principales:	Villarrubia, J., Calderon, E., Morado, M., Quintero, V., Vitoria, I., Torralba, M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429839/ http://dx.doi.org/10.1097/01.HS9.0000852268.99527.9a

Ejemplares similares

Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)
por: McGovern, Margaret M., et al.
Publicado: (2017)

Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)
por: Wasserstein, Melissa, et al.
Publicado: (2018)

PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY
por: Symeonidis, Argiris, et al.
Publicado: (2023)

Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months
por: Wasserstein, Melissa P., et al.
Publicado: (2018)

PB2361: DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDERLY: RETROSPECTIVE ANALYSIS FROM A SINGLE CANCER CENTER IN ALGIERS
por: Faiza, Talbi, et al.
Publicado: (2023)

Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults
por: Lachmann, Robin H., et al.
Publicado: (2023)

PB1939: CLINICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH GAUCHER DISEASE: A SINGLE CENTER EXPERIENCE
por: Elsayed, S., et al.
Publicado: (2022)

PB2314: OLIPUDASE ALFA FOR ADULTS WITH ACID SPHINGOMYELINASE DEFICIENCY: IMPROVEMENTS IN CROSSOVER PLACEBO PATIENTS AND FURTHER IMPROVEMENTS IN ORIGINAL OLIPUDASE ALFA PATIENTS AFTER 2 YEARS IN ASCEND TRIAL
por: Villarrubia, J., et al.
Publicado: (2022)

Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
por: Di Rocco, Maja, et al.
Publicado: (2023)

PB2493: PERIPHERAL NEUROPATHY A HIDDEN CAUSE FOR PAIN IN GAUCHER DISEASE.A CASE REPORT AND REVIEW OF LITERATURE
por: Abdel Gwad Tantawy, Azza, et al.
Publicado: (2023)

PB2544: GAUCHER-LIKE CELLS IN THALASSEMIA INTERMEDIA: IS IT A CHALLENGE?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis
por: Twilt, M, et al.
Publicado: (2013)

PB2024: PREVALENCE OF TYPE 1 GAUCHER DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: FIRST INTERIM ANALYSIS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY
por: Offidani, M., et al.
Publicado: (2022)

Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields
por: Allen, Caley, et al.
Publicado: (2022)

Identification of novel mutations in glucocerebrosidase (GBA) gene in Indian patients with gaucher disease (GD)
por: Ankleshwaria, Chitra, et al.
Publicado: (2014)

2361. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Zuccaro, Patricia, et al.
Publicado: (2019)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report
por: Thurberg, Beth L.
Publicado: (2020)

Sphingomyelinases and Liver Diseases
por: Insausti-Urkia, Naroa, et al.
Publicado: (2020)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

Assessment of quality of life in Gaucher disease: A methodological approach
por: Zizemer, Vitória S., et al.
Publicado: (2020)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Gaucher’s Disease
Publicado: (1916)

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.
por: Zahra, Kmira, et al.
Publicado: (2023)

The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher Disease
por: Torralba-Cabeza, Miguel-Ángel, et al.
Publicado: (2018)

2361. Factors Associated With Sepsis Development in Cellulitis. A Prospective Analysis of 606 Episodes in Adult Patients
por: Collazos, Julio, et al.
Publicado: (2018)

2361. Prevalence of Zoster Infection Post mRNA COVID-19 Vaccination Compared to Influenza Vaccination
por: Lazbin, Mark S, et al.
Publicado: (2023)

PB1817: PROGNOSTIC SIGNIFICANCE OF CD200 ON ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA AND ITS MECHANISM
por: Quan, X., et al.
Publicado: (2022)

New correlations between ocular parameters and disease severity in Spanish patients with Gaucher’s disease Type I
por: Esteban, Olivia, et al.
Publicado: (2021)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Gaucher disease: an update
por: Dumitrascu, Dan L.
Publicado: (2021)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Parkinson disease in Gaucher disease
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2017)

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361–2369
por: Vaisar, Tomas, et al.
Publicado: (2019)

Erratum. Exercise Effects on White Adipose Tissue: Beiging and Metabolic Adaptations. Diabetes 2015;64:2361–2368
por: Stanford, Kristin I., et al.
Publicado: (2015)

Neutral sphingomyelinase‐2 and cardiometabolic diseases
por: Sindhu, Sardar, et al.
Publicado: (2021)

Acidic Sphingomyelinase (ASM) Is Necessary for Fas-induced GD3 Ganglioside Accumulation and Efficient Apoptosis of Lymphoid Cells
por: De Maria, Ruggero, et al.
Publicado: (1998)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

PB2486: AN EFFECTIVE AND PRACTICAL CBC DELTA CHECK METHOD AND CRITERIA FOR THE QUALITY CONTROL OF AUTOMATIC HEMATOLOGY ANALYZERS
por: Kim, Min-Sun, et al.
Publicado: (2023)

PB1833: STREAMLINED WORKFLOW FOR ANALYZING AND REPORTING OPTICAL GENOME MAPPING FOR HEMATOLOGICAL MALIGNANCIES IN BIONANO VIA SOFTWARE
por: Hastie, Alex, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kge3k8s85nhp8kr6fv8efq6fke